Cytodyn Inc (CYDY)

[BlackDoggie]

Definitely valid to ask. My interpretation of Saltz's comments was more of a shades of grey sort of thing. I don't doubt that the test is superior and can produce significant revenues, etc. Maybe there are difficulties in getting it to market that were a bit glossed over? Maybe the revenue stream isn't sustainable due to lack of significant protection via exclusivity for some reason? Who knows. I'm sure many of us took statements to mean that the test getting approved, marketed, and adopted was the next best thing to a done deal. Probably, like most things, it appears clear and simple from the outside but is more complicated on the inside.

He definitely said in the September Q&A portion that prior to the acquisition his company was in talks about licensing deals, and that he believed that things could move quickly once the acquisition closed. Certain words there may mean different things to different people, but I don't believe that he would have outright lied about that.

I guess one day we'll all wake up and know the answer. I doubt it'll be next Wednesday, but I'd happily be surprised in that regard.